News Europe Suppliers Selected For Ireland’s Medical Cannabis Pilot

Suppliers Selected For Ireland’s Medical Cannabis Pilot

-

Advertising

TWO companies have been approved as the first suppliers to Ireland’s recently launched medical cannabis programme.

The Irish Government signed off on the launch of its five-year pilot in June, with Canadian firm Aurora and MGC Pharmaceuticals, of Australia, selected to provide its first cannabis medicine.

Under the scheme consultants can prescribe to patients for spasticity, associated with multiple sclerosis, chemotherapy-related intractable nausea and treatment-resistant epilepsy.

The two products are Aurora High CBD Oil Drops and CannEpil, both are CBD based drugs with the latter being used to treat epilepsy.

However, much like its UK neighbour there will be a time-lag of weeks between prescription and receipt of the drug.

The Irish Journal reports that under the scheme the two companies have to apply for a licence to bring the product into Ireland for distribution. 

CannEpil is a product that ‘has been years in the making’, and was released into the market in 2017, says Roby Zomer, Executive Director and CEO at MGC. 

The Medical Cannabis Access Programme was signed into law in June this year, by Ireland’s Minister for Health, Simon Harris. 

Mr Harris said at the time that the programme would allow ‘compassionate access to cannabis for medical reasons’ in cases where conventional treatment has failed.

The Irish Government says it wants to encourage the development of a home-grown cannabis cultivation and hemp industry saying it the potential to create over 80,000 jobs.

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

When Is The Best Time – And With Whom – To Launch The Required Toxicology Tests For A UK CBD Novel Food Pass?

FOOD regulators have unveiled further key details for CBD businesses looking to operate in the UK post-Brexit.

Europe’s CBD U-Turn Set To Cause Widespread Harm To Businesses And Consumers

CONFIRMATION that the European Union is looking to treat CBD as a narcotic drug have rocked the...

Europe’s CBD Brexit; On The Continent It’s Now A ‘Drug’ – In The UK It’s A Food

THE next few months look like being crucial for the CBD industry following confirmation the European Union...

£28m UK Horticultural Firm Turns To Cannabis: ‘We are learning More And More About This Fascinating Plant’

WITH the equivalent of over 35 football pitches of covered growing space and the potential to add...

Advertising

New MD To Usher In Era Of Change At Europe’s Largest Cannabis Trade Group

THE new Managing Director of the Cannabis Trades Association says it’s time for a re-set as she...

Can New Irish Government Deliver On Medicinal Cannabis? One-Year-Old Scheme Currently Has No Patients

IN June last year the Irish Government signed-off on its five-year medicinal cannabis programme - but no...

Must read

Advertising

You might also likeRELATED
Recommended to you